Review
Year 2016,
Volume: 2 Issue: 1, 63 - 68, 11.03.2016
Abstract
Hiponatremi en sık karşılaşılan elektrolit bozukluğudur. Hiponatremi, altta yatan nedene ve başlangıç şekline göre çok değişken klinik bulgular ile ortaya çıkabilir. Dolayısıyla, hiponatremi tedavisi her hastaya göre değişkenlik gösterir. Akut başlangıçlı hiponatremi beyin ödemine yol açabileceğinden acil tedavi gerektirirken, kronik hiponatremi agresif tedavi edilirse ozmotik demiyelinasyon sendromu adı verilen ciddi bir nörolojik tabloya yol açabilir. Bu derlemede hiponatremiye güncel yaklaşım olgu sunumları eşliğinde anlatıldı.
References
- Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014;29:1-39.
- Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342:1581-9.
- Adrogué HJ, Madias NE. The challenge of hyponatremia. J Am Soc Nephrol 2012;23:1140-8.
- Sterns RH. Disorders of plasma sodium--causes, consequences, and correction. N Engl J Med 2015;372:55-65.
- Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med 2006;119:30-5.
- Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 1985;102:164-8.
- Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979;236:321-32.
- Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis 2008;52:144-53.
- Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 2013;126:1-42.
- Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-112.
- Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J, et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010;21:705-12.
- Verbalis JG, Adler S, Schrier RW, Berl T, Zhao Q, Czerwiec FS. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol 2011;164:725-32.
Year 2016,
Volume: 2 Issue: 1, 63 - 68, 11.03.2016
Abstract
References
- Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014;29:1-39.
- Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342:1581-9.
- Adrogué HJ, Madias NE. The challenge of hyponatremia. J Am Soc Nephrol 2012;23:1140-8.
- Sterns RH. Disorders of plasma sodium--causes, consequences, and correction. N Engl J Med 2015;372:55-65.
- Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med 2006;119:30-5.
- Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 1985;102:164-8.
- Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979;236:321-32.
- Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis 2008;52:144-53.
- Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 2013;126:1-42.
- Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-112.
- Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J, et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010;21:705-12.
- Verbalis JG, Adler S, Schrier RW, Berl T, Zhao Q, Czerwiec FS. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol 2011;164:725-32.
There are 12 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Review |
| Authors | |
| Publication Date | March 11, 2016 |
| Published in Issue | Year 2016 Volume: 2 Issue: 1 |
